170 related articles for article (PubMed ID: 9918245)
21. Neurochemistry of the hippocampus in patients with obsessive-compulsive disorder.
Atmaca M; Yildirim H; Ozdemir H; Koc M; Ozler S; Tezcan E
Psychiatry Clin Neurosci; 2009 Aug; 63(4):486-90. PubMed ID: 19531109
[TBL] [Abstract][Full Text] [Related]
22. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study.
Blasi G; Bertolino A; Brudaglio F; Sciota D; Altamura M; Antonucci N; Scarabino T; Weinberger DR; Nardini M
Psychiatry Res; 2004 Jul; 131(2):95-105. PubMed ID: 15313516
[TBL] [Abstract][Full Text] [Related]
23. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
24. Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis.
Mathiesen HK; Jonsson A; Tscherning T; Hanson LG; Andresen J; Blinkenberg M; Paulson OB; Sorensen PS
Arch Neurol; 2006 Apr; 63(4):533-6. PubMed ID: 16606765
[TBL] [Abstract][Full Text] [Related]
25. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
26. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
[TBL] [Abstract][Full Text] [Related]
27. Neurochemical correlates of cognitive dysfunction in patients with leukoaraiosis: a proton magnetic resonance spectroscopy study.
Wang S; Yuan J; Guo X; Peng P; Gu H; Niu S; Fregni F; Chen AC; Hu W
Neurol Res; 2012 Dec; 34(10):989-97. PubMed ID: 23146302
[TBL] [Abstract][Full Text] [Related]
28. Chemical pathology in brain white matter of recently detoxified alcoholics: a 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury.
Schweinsburg BC; Taylor MJ; Alhassoon OM; Videen JS; Brown GG; Patterson TL; Berger F; Grant I
Alcohol Clin Exp Res; 2001 Jun; 25(6):924-34. PubMed ID: 11410730
[TBL] [Abstract][Full Text] [Related]
29. Brain injury and neurometabolic abnormalities in systemic lupus erythematosus.
Friedman SD; Stidley CA; Brooks WM; Hart BL; Sibbitt WL
Radiology; 1998 Oct; 209(1):79-84. PubMed ID: 9769816
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.
Sahin I; Alkan A; Keskin L; Cikim A; Karakas HM; Firat AK; Sigirci A
J Diabetes Complications; 2008; 22(4):254-60. PubMed ID: 18413166
[TBL] [Abstract][Full Text] [Related]
31. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
32. The relationship between white matter brain metabolites and cognition in normal aging: the GENIE study.
Charlton RA; McIntyre DJ; Howe FA; Morris RG; Markus HS
Brain Res; 2007 Aug; 1164():108-16. PubMed ID: 17632090
[TBL] [Abstract][Full Text] [Related]
33. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study.
Nordahl TE; Salo R; Natsuaki Y; Galloway GP; Waters C; Moore CD; Kile S; Buonocore MH
Arch Gen Psychiatry; 2005 Apr; 62(4):444-52. PubMed ID: 15809412
[TBL] [Abstract][Full Text] [Related]
34. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus.
Tomietto P; Annese V; D'agostini S; Venturini P; La Torre G; De Vita S; Ferraccioli GF
Arthritis Rheum; 2007 Dec; 57(8):1461-72. PubMed ID: 18050188
[TBL] [Abstract][Full Text] [Related]
35. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
36. White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination?
Fayed N; Morales H; Modrego PJ; Muñoz-Mingarro J
Acad Radiol; 2006 Feb; 13(2):229-35. PubMed ID: 16428059
[TBL] [Abstract][Full Text] [Related]
37. Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study.
Ainiala H; Dastidar P; Loukkola J; Lehtimäki T; Korpela M; Peltola J; Hietaharju A
Scand J Rheumatol; 2005; 34(5):376-82. PubMed ID: 16234185
[TBL] [Abstract][Full Text] [Related]
38. Proton magnetic resonance spectroscopy: normal findings in the cerebellar hemisphere in childhood.
Costa MO; Lacerda MT; Garcia Otaduy MC; Cerri GG; Da Costa Leite C
Pediatr Radiol; 2002 Nov; 32(11):787-92. PubMed ID: 12389106
[TBL] [Abstract][Full Text] [Related]
39. White-matter volume reduction and the protective effect of immunosuppressive therapy in systemic lupus erythematosus patients with normal appearance by conventional magnetic resonance imaging.
Xu J; Cheng Y; Chai P; Lu Z; Li H; Luo C; Li X; Li L; Zhou Q; Chen B; Cao J; Xu X; Shan B; Xu L; Wen J
J Rheumatol; 2010 May; 37(5):974-86. PubMed ID: 20231206
[TBL] [Abstract][Full Text] [Related]
40. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
Tong Z; Yamaki T; Harada K; Houkin K
Magn Reson Imaging; 2004 Sep; 22(7):1017-24. PubMed ID: 15288143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]